Prevalence of cervical cancer and associated mortality in Grenada, 2000–2010

Bahadoor-Yetman, A.; Riley, L.; Gibbons, A.; Fields, P. J.; Mapp-Alexander, V.

Prevalence of cervical cancer and associated mortality in Grenada, 2000–2010
Prevalencia del cáncer cervicouterino y mortalidad asociada en Granada, 2000-2010

Cite

Bahadoor-Yetman, A., Riley, L., Gibbons, A., Fields, P. J., & Mapp-Alexander, V. (2016). Prevalence of cervical cancer and associated mortality in Grenada, 2000–2010 [Journal articles]. https://iris.paho.org/handle/10665.2/28409

Files

v39n4a3_194-199.pdf (1.89 MB)

Date

2016

Authors

Bahadoor-Yetman, A.
Riley, L.
Gibbons, A.
Fields, P. J.
Mapp-Alexander, V.

Description

Objective. To assess cervical cancer prevalence and associated mortality in Grenada, West Indies during 2000–2010. Methods. Records of visits to hospital and clinical facilities were obtained from the histopathology laboratory of the Grenada General Hospital. Records were de-identified and electronically compiled. Cervical cancer prevalence was assessed via cross-sectional analysis of this secondary data. Of a total 12 012 records, 2 527 were selected for analysis using sampling without replacement. Cases were matched to corresponding patient data from death registries, where possible, and used to calculate associated mortality rates. Results. The observed prevalence of cervical cancer was 52.4 per 100 000 women (ages 15 and above). The highest rates of cervical cancer occurred in the 35–44 age group, with the second highest among 45–64-year-olds. A total of 65 deaths were attributable to cervical cancer during 2000–2010, more than 50% of which were among women > 65 years old. The observed mortality rate was 16.7 per 100 000, almost twice the rate estimated by WHO for the region. Conclusions. This study demonstrates the need for a comprehensive cervical cancer-screening program in Grenada. Results should contribute to informing future studies on how to appropriately generate and execute public health policy for education, screening, prevention, and control of cervical cancer in Grenada.

Objetivo. Evaluar la prevalencia del cáncer cervicouterino y la mortalidad asociada en Granada, Antillas Menores, entre el 2000 y el 2010. Métodos. Se obtuvieron los registros de las visitas al hospital y a consultorios clínicos a partir del laboratorio de histopatología del Hospital General de Granada. Se borraron los datos personales de los registros y se los compiló electrónicamente. La prevalencia de cáncer cervicouterino se evaluó por medio del análisis transversal de estos datos secundarios. De un total de 12 012 registros, fueron seleccionados para el análisis 2 527 mediante un método de muestreo sin reemplazo. Los casos se compararon con los datos correspondientes de pacientes en los registros de defunciones, cuando fue posible, y se usaron para calcular las tasas de mortalidad asociadas. Resultados. La prevalencia observada de cáncer cervicouterino fue 52,4 por 100 000 mujeres (de 15 años o más). Las tasas más elevadas de cáncer cervicouterino se observaron en el grupo de edad de 35 a 44 años, seguido por el grupo de 45 a 64 años. Del 2000 al 2010, 65 defunciones fueron atribuibles al cáncer cervicouterino, más del 50% en mujeres mayores de 65 años. La tasa de mortalidad observada fue 16,7 por 100 000, casi el doble de la calculada por la Organización Mundial de la Salud para la región. Conclusiones. Este estudio indica la necesidad de establecer un programa integral de detección del cáncer cervicouterino en Granada. Los resultados deben servir como base para estudios futuros sobre cómo generar y ejecutar apropiadamente políticas de salud pública para la educación en la materia, la detección, la prevención y el control del cáncer cervicouterino en Granada.

Citation

Bahadoor-Yetman A, Riley L, Gibbons A, Fields PJ, Mapp-Alexander V, Hage R et al. Prevalence of cervical cancer and associated mortality in Grenada: 2000–2010. Rev Panam Salud Publica. 2016; 39(4):194–99.

Collections

Pan American Journal of Public Health

Full item page

Related items

Showing items related by metadata.

Using focus groups to plan culturally acceptable primary cervical cancer screening in Grenada, West Indies
(2023) Hyacinth-Purcell, Calisha; Sylvester-Gill, Jeannine; Sperr, Edwin; McPherson, Jane; Baldwin, Amy
[ABSTRACT]. Objective. To document Grenadian women’s knowledge about cervical cancer and human papillomavirus (HPV) infection, as well as their attitudes towards primary cervical cancer screening methods. Methods. In this qualitative study, we used focus groups in Grenada to gather information concerning women’s knowledge about, attitudes towards and perceptions of screening for cervical cancer and general knowledge about HPV. Ten focus groups comprising 73 participants representing 5 of the 6 parishes in Grenada were conducted with women aged 19–59. Participants were asked about pelvic exams, Pap smears, HPV, reasons for seeking or avoiding cervical cancer screening and how different modalities of testing might affect their decision-making. Responses were then coded and organized into common themes. Results. While many respondents had heard of HPV, far fewer knew about its causative role in cervical can- cer, how to prevent HPV infection or testing for the high-risk HPV types that cause almost all cases of cervical cancer. Many participants were aware that cervical cancer screening was beneficial, but numerous barriers to obtaining that screening were noted, including concerns about privacy and stigma, potential discomfort, and the cost and inconvenience involved. Conclusions. Our findings have implications for future cervical cancer screening efforts in Grenada. Central to these efforts should be a focus on educating Grenadians about the role of HPV infection in cervical cancer and the importance of early detection through screening. In addition, addressing issues of stigma and privacy are key to eliminating cervical cancer in Grenada.
Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening
(2024) McGill, Frances; Fields, Paul J.; Bahadoor-Yetman, Aví; Manglardi, Erin Salter; Bailey, Ronelle; Padala, Kritika; et.al
[ABSTRACT]. Objective. To compare the adequacy, agreement, and acceptability of Papanicolaou testing (cytology) for cervical cancer screening using self-collected samples compared to physician-collected samples in Grenada in the Caribbean. Furthermore, the study identifies the human papillomavirus (HPV) genotypes present among asymptomatic women testing positive for HPV, the etiologic cause of cervical cancer. Methods. Participants were divided into two groups and two cervical samples were collected from the women in each group: a self-collected sample and a physician-collected sample. Cervical specimens were tested for cytology and HPV. HPV genotyping was performed on positive specimens. Results. Self-collected samples were adequate and in agreement with physician-collected samples, showing no difference between the two sampling methods. Oncogenic high-risk HPV genotypes were identified in cervical samples which were positive for atypical squamous cells and low-grade squamous intraepithelial lesions. The high-risk HPV genotypes found, notably HPV 45 and 53, differed from those most commonly reported. Although the commonly reported high-risk genotypes HPV 16 and 18 were found, so were 31, 33, 35, 52, 66, 68, and 82. Conclusions. Using self-collection facilitated the discovery of unexpected HPV genotypes among asymptomatic women in Grenada. These findings add new information to the literature regarding cervical cancer and neoplasia screening and HPV genotypes in the Caribbean. This genotype information may impact surveillance of women with low-grade lesions, HPV vaccine selection, and possibly further vaccine research. Research regarding HPV in Caribbean pathology samples of cervical neoplasia and cancer is needed.
Desigualdades espaciales y espacio-temporales en la mortalidad prematura por cáncer cervicouterino en Argentina (2001–2020)
(2025-08-22) Fattore, Gisel L.; Aráoz Olivos, Natalia; Leveau, Carlos M.; Ballejo, Christian; Delgado, Ana Laura; María Verónica, Pesce; Marro, María Jimena
[RESUMEN]. Objetivo. Estimar los años de vida perdidos (AVP) por cáncer cervicouterino (CCU) a nivel subnacional de Argentina en el período 2001-2020, e identificar conglomerados espaciales y espacio-temporales. Métodos. Estudio ecológico y de serie temporal. Los datos de óbitos fueron obtenidos de la Dirección de Estadísticas e Información en Salud y los datos de población de los censos del Instituto Nacional de Estadística y Censos y las proyecciones intercensales. Se estimaron tasas brutas y ajustadas por edad de AVP agrupadas en quinquenios, por provincias de Argentina. Se aplicaron técnicas de autocorrelación espacial, mediante el cálculo del índice de Moran e indicadores locales de asociación espacial y de escaneo estadístico espacio-temporal para detectar conglomerados espacio-temporales. Resultados. En el período 2001-2020 se registraron 37 265 óbitos por CCU, que correspondieron a 1 398 661 AVP. La tasa ajustada de AVP exhibió un aumento significativo entre el primer quinquenio (5,42 por 1 000; IC 95% 5,40-5,44) y el último (5,75 por 1 000; 5,73-5,76). Las provincias mostraron un comportamiento estable o en aumento, a excepción de Jujuy y Santa Cruz donde el descenso de los AVP fue significativo. Se constató una persistencia temporal de un conglomerado espacial en el norte del país; y de conglomerados espaciotemporales de altas tasas en la región Noroeste (Salta/Jujuy) durante 2001-2009 y Noreste en 2011-2020. Conclusiones. La mortalidad prematura por CCU en Argentina evidenció una tendencia al aumento, con mayor concentración en provincias del norte. El descenso observado en algunas provincias podría atribuirse, en parte, a diferencias en la implementación de programas de prevención.
Implementation of second round of HPV-based screening for cervical cancer in programmatic contexts in Argentina
(2025-08-28) Barcena Barbeira, Pilar; Paolino, Melisa; Binder, Fernando; Almonte, Maribel; Baena, Armando; Mazzadi, Juan David; Arrossi, Silvina
[ABSTRACT]. Objectives. To evaluate implementation of the second round of human papillomavirus (HPV)-based cervical screening, introduced in Argentina in 2012–2014 through the Jujuy Demonstration Project for women 30 years and older, and describe the characteristics of women who adhere to the recommended five-year rescreening interval. Methods. A retrospective cohort study was conducted based on the data of two rounds of screening. All women aged 30 years or older who had been HPV-tested during the Jujuy Demonstration Project and had a negative result were included. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was used to evaluate implementation. Multivariable regression was used to examine fac- tors associated with adherence to rescreening. Results. Of 42 307 HPV-negative women, 47.9% (n = 20 285) were rescreened in the second round (Reach); 69.2% of health centers provided at least one HPV test at second-round screening (Adoption); and 13.3% (n = 5 639) of women were rescreened within the recommended five-year interval. Among the total rescreened, 9.3% (n = 1 888) were HPV-positive, of which 95.0% underwent triage Pap and 79.2% of the HPV-positive/ abnormal Pap women had colposcopy. Considering women rescreened at five years, the second-round detection rate was 5.3/1 000 screened women. Rescreening at five years was significantly higher among women aged 30–44, with public health insurance, and those living in the provincial capital. Conclusions. Rescreening of HPV-negative women faced challenges linked to its reduced reach, especially if we consider the recommended five-year interval. Our findings suggest that we need to devise specific strategies to increase second-round screening rates.
HIV prevalence among cervical (pre)cancer diagnoses in Suriname: a retrospective population study
(2024-11-11) Stijnberg, Deborah; Charles, Regillio; Mc Kee, Mike; Chan, Mikel; Grunberg, Antoon; Schrooten, Ward; Adhin, Malti
[ABSTRACT]. Objective. To determine the prevalence of HIV in women with (pre)cancerous cervical lesions in Suriname and their retention in care. Methods. A retrospective population study including all women diagnosed with (pre)invasive cervical intraepithelial neoplasia (CIN I to III or cervical cancer) in the only pathology department, during 2010–2020. The HIV test coverage and the HIV positivity ratio were determined through matching pathology data with the national HIV test database. The relation between retention in HIV care up to 2022 and different covariates was determined through Kaplan–Meier survival analysis and log-rank tests. Results. There were 2 901 (1 395 CIN I, 396 CIN II, 444 CIN III, and 666 cervical cancer) diagnoses of (pre) invasive cervical neoplasia. An overall HIV test coverage of 57.5% and a positivity ratio of 5.8% were found, with no difference among the (pre)cancer stages. The undiagnosed prevalence (women not previously known HIV-positive at cervical diagnosis) was 1.6% and 2.9% among precancer and cancer diagnoses, respectively. The median time in care of women with cervical cancer was 8 months for those not on antiretroviral therapy (ART) and 4 years for those starting ART. Among women with precancer stages this was 5 and 10 years, respectively (p < 0.05). Conclusions. HIV testing, followed by treatment initiation when found HIV-positive, should be prioritized in women diagnosed with cervical neoplasia. This will enhance the individual clinical outcomes and facilitate the control of the HIV epidemic in Suriname.